NHS Digital Data Release Register - reformatted
Project 1 — DARS-NIC-147858-KGYSS
Opt outs honoured: N
Sensitive: Sensitive, and Non Sensitive
When: 2016/04 (or before) — 2018/05.
Legal basis: Informed Patient consent to permit the receipt, processing and release of data by the HSCIC
- MRIS - Cause of Death Report
- MRIS - Cohort Event Notification Report
The role of selective neck dissection used electively in patients with early oral squamous cell carcinoma (1−3cm primary size) and no clinical evidence of lymph node metastases in the neck (N0) The trial aims to establish whether selective neck dissection in addition to resection of the primary tumour increases survival when compared with resection of the primary alone, among patients with early oral squamous cell carcinoma who have no clinical or radiological evidence of neck metastases. Additionally the trial aims to determine how SEND and complex reconstruction affect quality of life (QOL) and whether the use of SEND on all patients presenting with tumors measuring 1-3cms and clinically N0 necks represents a cost-effective use of resources. We will also use the pathology results to try to identify risk factors for metastasis so that in the future elective neck dissection could be reserved for only those patients with an increased risk of neck metastasis based on their primary site pathological markers. Data access is restricted to those named in section 7 of this agreement. Any changes will be notified to the NHS IC.